Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

4.90
Delayed Data
As of Jan 17
 -0.10 / -2.00%
Today’s Change
4.32
Today|||52-Week Range
7.57
-3.92%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close5.00
Today’s open4.95
Day’s range4.83 - 4.97
Volume173,125
Average volume (3 months)127,666
Market cap$254.5M
Dividend yield--
Data as of 4:00pm ET, 01/17/2017

Growth & Valuation

Earnings growth (last year)-73.91%
Earnings growth (this year)-55.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-24.99%
P/E ratioNM
Price/Sales34.74
Price/Book2.81

Competitors

 Today’s
change
Today’s
% change
RIGLRigel Pharmaceutical...-0.17-6.77%
SELBSelecta Biosciences ...-0.30-1.98%
SYRSSyros Pharmaceutical...-0.22-1.85%
PIPPharmAthene Inc-0.05-1.47%
Data as of 4:01pm ET, 01/17/2017

Financials

Next reporting dateFebruary 14, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$9.3M
Annual profit (last year)-$20.2M
Net profit margin-217.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Operating &
Financial Officer
Ari Krashin
Corporate headquarters
Holon, Tel Aviv

Forecasts


Search for Jobs